Resmed Inc (NYSE: RSMDF)

ResMed Inc., a prominent player in the digital health and cloud-connected medical devices sector, operates within the sleep and respiratory care industry. The company is renowned for its innovative solutions that aim to keep people out of the hospital, thereby empowering them to lead healthier, higher-quality lives. ResMed's comprehensive out-of-hospital (OOH) software platform supports professionals and caregivers in maintaining the health of individuals in their chosen care setting.

The core of ResMed's business revolves around its Sleep and Respiratory Care segment. This segment encompasses a range of products such as CPAP systems, bilevel devices, high-flow therapy devices, non-invasive and invasive ventilators, humidifiers, and accessories. Additionally, the company provides software solutions, including AirView, a patient management and engagement platform, and myAir, a patient engagement application that offers sleep coaching and a daily score based on users' sleep data.

ResMed's Sleep and Respiratory Care segment is the company's primary focus, dedicated to the diagnosis and treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other chronic respiratory diseases. The company's products are utilized in over 140 countries with the primary objective of enhancing patient outcomes, increasing patient comfort and convenience, and promoting adherence to prescribed therapy.

In the competitive landscape of the sleep and respiratory care industry, ResMed faces competition from medical device companies specializing in sleep apnea and COPD treatment, such as Philips Healthcare and Fisher & Paykel Healthcare. However, ResMed maintains a competitive edge through its innovative products, strong brand recognition, and extensive global distribution network.

ResMed's customers span across sleep clinics, home healthcare dealers, patients, and third-party payors. The company's products are employed by healthcare professionals and caregivers to treat patients with sleep apnea, COPD, and other chronic respiratory diseases. Some of ResMed's notable customers include major healthcare systems, home healthcare agencies, and sleep clinics.

ResMed's product portfolio comprises devices, diagnostic products, mask systems, headgear, and other accessories. The device range includes cloud-connected CPAP, automatic positive airway pressure (APAP), bilevel, adaptive servo-ventilation (ASV), and high-flow therapy (HFT) devices. The diagnostic product line features sleep recorders and oximeters, while mask systems consist of nasal, nasal pillows, and full-face masks.

In terms of sales and marketing, ResMed utilizes a network of distributors and direct sales staff. The company employs a combination of its direct sales force and independent distributors to sell its products in over 140 countries. In the United States, Canada, and Latin America, ResMed's products are typically purchased by a home healthcare dealer who then sells the products to the patient.

ResMed's manufacturing operations involve specialist component production, technical assembly, and comprehensive testing and quality control of its devices, masks, and accessories. The company operates a globally distributed manufacturing network designed to optimize quality, control costs, reduce time to market for new product introduction, and generate supply chain resilience.

ResMed's quality management system adheres to the requirements of ISO 13485, FDA Quality Management System Regulation, European Medical Device Regulation, and other applicable regulations for the markets in which the company sells its products. The company's main manufacturing sites are certified to ISO 13485 and are regularly audited by a Notified Body.